Quetiapine and rivastigmine for agitation in Alzheimer’s disease

被引：1
|
作者：
Raymond L. Ownby
机构：
来源：
Current Psychiatry Reports | 2006年 / 8卷 / 1期
关键词：
Cognitive Decline; Cholinesterase; Quetiapine; Rofecoxib; Rivastigmine;
D O I：
10.1007/s11920-006-0075-2
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：10 / 10
相关论文
共 50 条
  • [1] Quetiapine in the treatment of agitation in patients with Alzheimer's disease
    Zhong, K
    Tariot, P
    Minkwitz, M
    Devine, N
    Mintzer, J
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 325 - 326
  • [2] The Effect of Adding Mirtazapine to Quetiapine on Reducing Agitation in Patients with Alzheimer's Disease
    Sayadnasiri, Mohammad
    Darvishskandari, Sahar
    Latifian, Maryam
    Islam, Sheikh Mohammed Shariful
    JOURNAL OF ALZHEIMERS DISEASE REPORTS, 2024, 8 (01) : 143 - 150
  • [3] Rivastigmine for Alzheimer's disease
    Birks, Jacqueline
    Evans, John Grimley
    Iakovidou, Vasso
    Tsolaki, Magda
    Holt, Francesca E.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (02):
  • [4] Rivastigmine for Alzheimer's disease
    Birks, Jacqueline S.
    Chong, Lee Yee
    Evans, John Grimley
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (09):
  • [5] Rivastigmine for Alzheimer's disease
    Birks, Jacqueline S.
    Evans, John Grimley
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (04):
  • [6] Rivastigmine in the treatment of Alzheimer's disease
    Deleu, D
    EUROPEAN NEUROLOGY, 2001, 46 (02) : 111 - 111
  • [7] Evaluation of rivastigmine in Alzheimer's disease
    Nguyen, Kevin
    Hoffman, Heidi
    Chakkamparambil, Binu
    Grossberg, George T.
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2021, 11 (01) : 35 - 48
  • [8] Rivastigmine in the pharmacotherapy of Alzheimer's disease
    Volz, HP
    Maurer, I
    PSYCHOPHARMAKOTHERAPIE, 2001, 8 (03): : 104 - 110
  • [9] Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial
    Ballard, C
    Margallo-Lana, M
    Juszczak, E
    Douglas, S
    Swann, A
    Thomas, A
    O'Brien, J
    Everratt, A
    Sadler, S
    Maddison, C
    Lee, L
    Bannister, C
    Elvish, R
    Jacoby, R
    BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7496): : 874 - 877
  • [10] The efficacy of rivastigmine (exelon) for treatment of agitation in Alzheimer's disease patients: The caregivers' voice and clinical experience
    Sofield, L
    Shua-Haim, J
    Pass, M
    GERONTOLOGIST, 2003, 43 : 303 - 304
12345